(Health Korea News / Changyong Lee) ‘Pharmaceutical 24 Hours’ is a corner that shows brief news related to pharmaceutical and biotechnology at a glance that is easy to miss. It may seem like trivial news, but it could be valuable information to someone, so we summarize the facts and present them in an easy-to-understand manner.
◆ Kukje Pharmaceutical signs an industry-academic cooperation agreement with ‘Korea Biomeister High School’ to foster bio talent
Kukje Pharmaceutical and Korea Biomeister High School have joined hands to actively cope with the era of infinite competition in the 21st century and nurture creative and outstanding talents who can meet the demands of the knowledge and information society.
Kukje Pharmaceutical signed a business agreement (MOU) with Korea Biomeister High School on the 17th to cooperate in nurturing and supplying excellent high school graduates.
According to the agreement, Korea Biomeister High School will be able to receive support for field education such as ‘production site tours’, ‘internships and field training’, and ‘special lectures by industry professional technology instructors’, and will be selected to special classes to cultivate talent in the biopharmaceutical field. It is now possible to operate a ‘corporate customized class’.
On this day, Kukje Pharmaceutical promised to hire students who completed the corporate customized class at Korea Biomeister High School in the quality control and manufacturing process fields. This is Kukje Pharmaceutical’s will to fulfill its social responsibility through job creation. Kukje Pharmaceutical has been able to secure a stable workforce of excellent human resources in the biopharmaceutical field.
◆ Korea United Pharmaceutical conducts a global talent development program with Cheorwon-gun, Gangwon-do
United Pharmaceutical Korea conducted the ’16th United Global Talent Development Program’ with Cheorwon-gun, Gangwon-do from the 15th to the 16th.
The global talent development program, which marks its 16th anniversary this year through a sisterhood relationship between Korea United Pharmaceutical and Cheorwon-gun, selects 20 elementary school students in Cheorwon-gun with excellent learning attitudes and good behavior and provides experiential learning, field trips, lectures, etc. to foster leadership. It is a social contribution activity that helps.
This program was conducted as a two-day, one-night program, after visiting the Yongsan War Memorial of Korea and the National Museum of Modern and Contemporary Art in Gwacheon on the first day, the participants entered the United Pharmaceutical Training Center located in Gwangju, Gyeonggi-do. On the second day, an instructor from the Korea Young Leadership Center was invited to give a leadership lecture under the theme of ‘In Search of Leadership’, and the global talent development program was concluded by awarding scholarship certificates and souvenirs to participating students.
◆ GCCL presented two posters on cell-mediated immunogenicity analysis research results at the Korean Society of Immunology
GCCL, a clinical trial sample analysis agency, plans to participate in the Korean Society of Immunology Fall Conference (Cytokines 2024 & KAI 2024) to be held at COEX, Seoul from October 20th to 23rd and present two research results related to cell-mediated immunogenicity analysis. .
The first published study is ‘Study on optimization of multiplex ELISpot analysis method using three types of fluorescence’. When evaluating cell-mediated immunogenicity of clinical trial subjects, PBMC (peripheral blood mononuclear cells) are separated from the blood and cytokines secreted by immune cells are measured using ELISpot. GCCL achieved the result of reducing the amount of blood required by one-third compared to the previous method by simultaneously analyzing IFN-γ, TNF-α, and IL-5 in one sample with three different colors of fluorescence. Through this, the burden of blood collection on subjects can be greatly reduced and more blood analysis items can be added at the same time, which is expected to greatly improve the efficiency and convenience of clinical sample analysis.
The second presentation is a study on ‘Stability of immunophenotyping analysis following ultra-low temperature long-term storage of PBMC’. When analyzing PBMCs isolated from blood during clinical trials, the PBMCs are collected and analyzed at once to reduce variation between analyzes. However, if PBMCs are stored for a long time, there is a risk that the results may vary depending on the time of analysis. GCCL selected representative CD markers through research based on its previous experience and confirmed that PBMCs maintain stability even when stored for up to 24 months at ultra-low temperatures (below -150°C). This is an important indicator in establishing long-term follow-up sample storage and analysis plans in clinical trials, and is evaluated as an important research achievement that can improve the quality of sample analysis in the central lab by analyzing frozen PBMCs at once.
◆ Bukwang Pharmaceutical holds an event to celebrate its 64th anniversary.
Bukwang Pharmaceutical held an award event and town hall meeting on the 17th to celebrate its 64th anniversary.
At this event, in addition to long-term service awards, an in-house award ceremony was held for the first time since its founding. The in-house awards included the ▲BK Award (Exemplary Employee Award) ▲Value Creation Award (Value Creation Award) ▲Outstanding Contribution Award (Special Contribution Award) ▲SH&E Award (Safety, Health, and Environment Award).
At this town hall meeting, which was held in conjunction with various award events, CEO Lee Je-young directly listened to the opinions of executives and employees and created an opportunity for active communication. At this town hall meeting, team leaders from the company’s four headquarters freely expressed their opinions on the ‘future of Bukwang Pharmaceutical.’ The town hall meeting, which was conducted for the purpose of strengthening internal communication, was held for the first time since its founding early this year, and this is the second event.
Copyright © Health Korea News Unauthorized reproduction and redistribution prohibited
Source: www.hkn24.com
